This study evaluated a synthetic KYNA analog’s effects on TNF-α, S100A8/9, S100A12, α-defensin, and interleukin-17 (IL-17) production and TSG-6 expression in ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Here, S100A12 is linked to ankylosing spondylitis.